{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:06:15Z","timestamp":1778087175306,"version":"3.51.4"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07537-5","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:55:00Z","timestamp":1765605300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulation of drug resistance in bladder urothelial carcinoma by tumor aerobic glycolysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Can","family":"Weng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoxuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuru","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6413-0213","authenticated-orcid":false,"given":"Chunping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"7537_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"7537_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. Jama. 2020;324:1980\u201391. https:\/\/doi.org\/10.1001\/jama.2020.17598","journal-title":"Jama"},{"key":"7537_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41585-020-00404-6","volume":"18","author":"DM Jiang","year":"2021","unstructured":"Jiang DM, Gupta S, Kitchlu A, Meraz-Munoz A, North SA, Alimohamed NS, Blais N, Sridhar SS. Defining cisplatin eligibility in patients with muscle-invasive bladder cancer. Nat Rev Urol. 2021;18:104\u201314. https:\/\/doi.org\/10.1038\/s41585-020-00404-6","journal-title":"Nat Rev Urol"},{"key":"7537_CR4","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/s43018-024-00822-0","volume":"5","author":"K Li","year":"2024","unstructured":"Li K, Zhong W, Fan J, Wang S, Yu D, Xu T, Lyu J, Wu S, Qin T, Wu Z, Xu L, Wu K, Liu Z, Hu Z, Li F, Wang J, Wang Q, Min J, Zhang Z, Yu L, Ding S, Huang L, Zhao T, Huang J, Lin T. Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial. Nat Cancer. 2024;5:1465\u201378. https:\/\/doi.org\/10.1038\/s43018-024-00822-0","journal-title":"Nat Cancer"},{"key":"7537_CR5","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/s0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat E, Amin MB, Cathomas R, Choudhury A, Santis MD, Kamat A, Stenzl A, Thoeny HC, Witjes JA. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet. 2022;400:1712\u201321. https:\/\/doi.org\/10.1016\/s0140-6736(22)01188-6","journal-title":"Lancet"},{"key":"7537_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","volume":"24","author":"MD Martino","year":"2024","unstructured":"Martino MD, Rathmell JC, Galluzzi L, Vanpouille-Box C. Cancer cell metabolism and antitumour immunity. Nat Rev: Immunol. 2024;24:654\u201369. https:\/\/doi.org\/10.1038\/s41577-024-01026-4","journal-title":"Nat Rev: Immunol"},{"key":"7537_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev: Cancer. 2021;21:669\u201380. https:\/\/doi.org\/10.1038\/s41568-021-00378-6","journal-title":"Nat Rev: Cancer"},{"key":"7537_CR8","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, Cao C, Wang Q, Zhao X, Huang Z, Chen S, Chen H, Fan Q, Deng F, Hou L, Deng X, Tan W. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 2024;73:101059. https:\/\/doi.org\/10.1016\/j.drup.2024.101059","journal-title":"Drug Resist Updat"},{"key":"7537_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41392-020-00326-0","volume":"5","author":"HQ Ju","year":"2020","unstructured":"Ju HQ, Lin JF, Tian T, Xie D, Xu RH. NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications. Signal Transduct Target Ther. 2020;5:231. https:\/\/doi.org\/10.1038\/s41392-020-00326-0","journal-title":"Signal Transduct Target Ther"},{"key":"7537_CR10","doi-asserted-by":"publisher","first-page":"116829","DOI":"10.1016\/j.biopha.2024.116829","volume":"176","author":"L Wu","year":"2024","unstructured":"Wu L, Hu Z, Song XF, Liao YJ, Xiahou JH, Li Y, Zhang ZH. Targeting Nrf2 signaling pathways in the role of bladder cancer: from signal network to targeted therapy. Biomed Pharmacother. 2024;176:116829. https:\/\/doi.org\/10.1016\/j.biopha.2024.116829","journal-title":"Biomed Pharmacother"},{"key":"7537_CR11","doi-asserted-by":"publisher","first-page":"e2300763120","DOI":"10.1073\/pnas.2300763120","volume":"120","author":"Y Ko","year":"2023","unstructured":"Ko Y, Hong M, Lee S, Kumar M, Ibrahim L, Nutsch K, Stanton C, Sondermann P, Sandoval B, Bulos ML, Iaconelli J, Chatterjee AK, Wiseman RL, Schultz PG, Bollong MJ. S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling. Proc Natl Acad Sci U S A. 2023;120:e2300763120. https:\/\/doi.org\/10.1073\/pnas.2300763120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7537_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.freeradbiomed.2024.11.001","volume":"226","author":"L Fan","year":"2025","unstructured":"Fan L, Guo D, Zhu C, Gao C, Wang Y, Yin F, Liu M, Zhou Y, Wei T, Xiong X, Yu K, Le A. LRRC45 accelerates bladder cancer development and ferroptosis inhibition via stabilizing NRF2 by competitively KEAP1 interaction. Free Radical Biol And Med. 2025;226:29\u201342. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.11.001","journal-title":"Free Radical Biol And Med"},{"key":"7537_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","volume":"22","author":"Y Mitsuishi","year":"2012","unstructured":"Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, Motohashi H. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 2012;22:66\u201379. https:\/\/doi.org\/10.1016\/j.ccr.2012.05.016","journal-title":"Cancer Cell"},{"key":"7537_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM DeNicola","year":"2011","unstructured":"DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, Scrimieri F, Winter JM, Hruban RH, Iacobuzio-Donahue C, Kern SE, Blair IA, Tuveson DA. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475:106\u201309. https:\/\/doi.org\/10.1038\/nature10189","journal-title":"Nature"},{"key":"7537_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12935-024-03570-4","volume":"24","author":"Y Yan","year":"2024","unstructured":"Yan Y, Huang Z, Zhu Z, Wang Y, Cao X, Yang C, Jiang J, Xia S, Shen B. IMP2 drives chemoresistance by repressing cisplatin-induced apoptosis and ferroptosis via activation of IPO4 and SLC7A11 under hypoxia in bladder cancer. Cancer Cell Int. 2024;24:386. https:\/\/doi.org\/10.1186\/s12935-024-03570-4","journal-title":"Cancer Cell Int"},{"key":"7537_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X, Deng G. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9:55. https:\/\/doi.org\/10.1038\/s41392-024-01769-5","journal-title":"Signal Transduct Target Ther"},{"key":"7537_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"J Guo","year":"2018","unstructured":"Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, Dai X, Li Z, Wu G. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res And Treat. 2018;50:445\u201360. https:\/\/doi.org\/10.4143\/crt.2016.572","journal-title":"Cancer Res And Treat"},{"key":"7537_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41420-022-01218-8","volume":"8","author":"D Gong","year":"2022","unstructured":"Gong D, Chen M, Wang Y, Shi J, Hou Y. Role of ferroptosis on tumor progression and immunotherapy. Cell Death Discov. 2022;8:427. https:\/\/doi.org\/10.1038\/s41420-022-01218-8","journal-title":"Cell Death Discov"},{"key":"7537_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-024-02088-5","volume":"10","author":"F Alves","year":"2025","unstructured":"Alves F, Lane D, Nguyen TPM, Bush AI, Ayton S. In defence of ferroptosis. Signal Transduct Target Ther. 2025;10:2. https:\/\/doi.org\/10.1038\/s41392-024-02088-5","journal-title":"Signal Transduct Target Ther"},{"key":"7537_CR20","doi-asserted-by":"publisher","unstructured":"Zhao Y, Ren P, Yang Z, Wang L, Hu C. Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis. Oncol Rep. 2023;49. https:\/\/doi.org\/10.3892\/or.2022.8453","DOI":"10.3892\/or.2022.8453"},{"key":"7537_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.urolonc.2014.02.006","volume":"32","author":"A Hayden","year":"2014","unstructured":"Hayden A, Douglas J, Sommerlad M, Andrews L, Gould K, Hussain S, Thomas GJ, Packham G, Crabb SJ. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer. Urologic Oncol. 2014;32:806\u201314. https:\/\/doi.org\/10.1016\/j.urolonc.2014.02.006","journal-title":"Urologic Oncol"},{"key":"7537_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.mito.2016.08.009","volume":"30","author":"D Zhang","year":"2016","unstructured":"Zhang D, Yip YM, Li L. In silico construction of HK2-VDAC1 complex and investigating the HK2 binding-induced molecular gating mechanism of VDAC1. Mitochondrion. 2016;30:222\u201328. https:\/\/doi.org\/10.1016\/j.mito.2016.08.009","journal-title":"Mitochondrion"},{"key":"7537_CR23","doi-asserted-by":"publisher","unstructured":"Bryan N, Raisch KP. Identification of a mitochondrial-binding site on the N-terminal end of hexokinase II. Biosci Rep. 2015;35. https:\/\/doi.org\/10.1042\/bsr20150047","DOI":"10.1042\/bsr20150047"},{"key":"7537_CR24","doi-asserted-by":"publisher","first-page":"1200538","DOI":"10.3389\/fphar.2023.1200538","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Lu H, Wang X, Liu Q, Hu J, Liu Y, Jin M, Kong D. Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC. Front Pharmacol. 2023;14:1200538. https:\/\/doi.org\/10.3389\/fphar.2023.1200538","journal-title":"Front Pharmacol"},{"key":"7537_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ccell.2018.12.012","volume":"35","author":"J Kim","year":"2019","unstructured":"Kim J, Yu L, Chen W, Xu Y, Wu M, Todorova D, Tang Q, Feng B, Jiang L, He J, Chen G, Fu X, Xu Y. Wild-type p53 promotes cancer metabolic switch by inducing PUMA-Dependent suppression of oxidative phosphorylation. Cancer Cell. 2019;35:191\u2013203.e8. https:\/\/doi.org\/10.1016\/j.ccell.2018.12.012","journal-title":"Cancer Cell"},{"key":"7537_CR26","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53-p21-RB signaling. Cell Death And Differentiation. 2022;29:946\u201360. https:\/\/doi.org\/10.1038\/s41418-022-00988-z","journal-title":"Cell Death And Differentiation"},{"key":"7537_CR27","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1158\/0008-5472.Can-17-2528","volume":"78","author":"K Daizumoto","year":"2018","unstructured":"Daizumoto K, Yoshimaru T, Matsushita Y, Fukawa T, Uehara H, Ono M, Komatsu M, Kanayama HO, Katagiri T. A DDX31\/Mutant-p53\/EGFR axis promotes multistep progression of muscle-invasive bladder cancer. Cancer Res. 2018;78:2233\u201347. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-2528","journal-title":"Cancer Res"},{"key":"7537_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D. Bladder cancer. Nat Rev Dis Primers. 2023;9:58. https:\/\/doi.org\/10.1038\/s41572-023-00468-9","journal-title":"Nat Rev Dis Primers"},{"key":"7537_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13046-020-01544-8","volume":"39","author":"X Peng","year":"2020","unstructured":"Peng X, Gao H, Xu R, Wang H, Mei J, Liu C. Correction to: the interplay between HIF-1\u03b1 and noncoding RNAs in cancer. J Exp Clin Cancer Res. 2020;39:45. https:\/\/doi.org\/10.1186\/s13046-020-01544-8","journal-title":"J Exp Clin Cancer Res"},{"key":"7537_CR30","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cac2.12158","volume":"41","author":"JZ Wang","year":"2021","unstructured":"Wang JZ, Zhu W, Han J, Yang X, Zhou R, Lu HC, Yu H, Yuan WB, Li PC, Tao J, Lu Q, Wei JF, Yang H. The role of the HIF-1\u03b1\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer. Cancer Commun (lond). 2021;41:560\u201375. https:\/\/doi.org\/10.1002\/cac2.12158","journal-title":"Cancer Commun (lond)"},{"key":"7537_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5732\/cjc.011.10446","volume":"31","author":"Z Lu","year":"2012","unstructured":"Lu Z. Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis. Chin J Cancer. 2012;31:5\u20137. https:\/\/doi.org\/10.5732\/cjc.011.10446","journal-title":"Chin J Cancer"},{"key":"7537_CR32","doi-asserted-by":"publisher","first-page":"15171","DOI":"10.1038\/s41598-023-41133-1","volume":"13","author":"T Sobanski","year":"2023","unstructured":"Sobanski T, Suraweera A, Burgess JT, Richard I, Cheong CM, Dave K, Rose M, Adams MN, O\u2019Byrne KJ, Richard DJ, Bolderson E. The fructose-bisphosphate, aldolase a (ALDOA), facilitates DNA-PKcs and atm kinase activity to regulate DNA double-strand break repair. Sci Rep. 2023;13:15171. https:\/\/doi.org\/10.1038\/s41598-023-41133-1","journal-title":"Sci Rep"},{"key":"7537_CR33","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1038\/onc.2014.167","volume":"34","author":"Y Yan","year":"2015","unstructured":"Yan Y, Hein AL, Greer PM, Wang Z, Kolb RH, Batra SK, Cowan KH. A novel function of HER2\/Neu in the activation of G2\/M checkpoint in response to \u03b3-irradiation. Oncogene. 2015;34:2215\u201326. https:\/\/doi.org\/10.1038\/onc.2014.167","journal-title":"Oncogene"},{"key":"7537_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12964-025-02047-9","volume":"23","author":"F Sun","year":"2025","unstructured":"Sun F, Li W, Du R, Liu M, Cheng Y, Ma J, Yan S. Impact of glycolysis enzymes and metabolites in regulating DNA damage repair in tumorigenesis and therapy. Cell Commun Signal. 2025;23:44. https:\/\/doi.org\/10.1186\/s12964-025-02047-9","journal-title":"Cell Commun Signal"},{"key":"7537_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1158\/1078-0432.Ccr-09-1029","volume":"16","author":"Y Dai","year":"2010","unstructured":"Dai Y, Grant S. New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res. 2010;16:376\u201383. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-09-1029","journal-title":"Clin Cancer Res"},{"key":"7537_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00018-023-05094-y","volume":"81","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu L, Qi Y, Lou J, Chen Y, Liu C, Li H, Chang X, Hu Z, Li Y, Zhang Y, Feng C, Zhou Y, Zhai Y, Li C. Lactic acid promotes nucleus pulposus cell senescence and corresponding intervertebral disc degeneration via interacting with Akt. Cell Mol Life Sci. 2024;81:24. https:\/\/doi.org\/10.1007\/s00018-023-05094-y","journal-title":"Cell Mol Life Sci"},{"key":"7537_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094390","author":"J Horv\u00e1thov\u00e1","year":"2021","unstructured":"Horv\u00e1thov\u00e1 J, Morav\u010d\u00edk R, Mat\u00fa\u0161kov\u00e1 M, \u0160i\u0161ovsk\u00fd V, Boh\u00e1\u010d A, Zeman M. Inhibition of glycolysis suppresses cell proliferation and tumor progression in vivo: perspectives for chronotherapy. Int J Mol Sci. 2021, 22. https:\/\/doi.org\/10.3390\/ijms22094390","journal-title":"Int J Mol Sci"},{"key":"7537_CR38","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.18632\/oncotarget.6482","volume":"7","author":"CC Li","year":"2016","unstructured":"Li CC, Yang JC, Lu MC, Lee CL, Peng CY, Hsu WY, Dai YH, Chang FR, Zhang DY, Wu WJ, Wu YC. ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer. Oncotarget. 2016;7:1947\u201359. https:\/\/doi.org\/10.18632\/oncotarget.6482","journal-title":"Oncotarget"},{"key":"7537_CR39","doi-asserted-by":"publisher","unstructured":"Song J, Sun H, Zhang S, Shan C. The multiple roles of glucose-6-phosphate dehydrogenase in Tumorigenesis and cancer chemoresistance. Life (Basel). 2022, 12. https:\/\/doi.org\/10.3390\/life12020271","DOI":"10.3390\/life12020271"},{"key":"7537_CR40","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s13238-014-0082-8","volume":"5","author":"P Jiang","year":"2014","unstructured":"Jiang P, Du W, Wu M. Regulation of the pentose phosphate pathway in cancer. Protein Cell. 2014;5:592\u2013602. https:\/\/doi.org\/10.1007\/s13238-014-0082-8","journal-title":"Protein Cell"},{"key":"7537_CR41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","volume":"39","author":"KC Patra","year":"2014","unstructured":"Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends In Biochemical Sci. 2014;39:347\u201354. https:\/\/doi.org\/10.1016\/j.tibs.2014.06.005","journal-title":"Trends In Biochemical Sci"},{"key":"7537_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.canlet.2014.01.017","volume":"356","author":"KM Aird","year":"2015","unstructured":"Aird KM, Zhang R. Nucleotide metabolism, oncogene-induced senescence and cancer. Cancer Lett. 2015;356:204\u201310. https:\/\/doi.org\/10.1016\/j.canlet.2014.01.017","journal-title":"Cancer Lett"},{"key":"7537_CR43","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/cac2.12532","volume":"44","author":"Z Tong","year":"2024","unstructured":"Tong Z, Zhao Y, Bai S, Ebner B, Lienhard L, Zhao Y, Wang Z, Pan Q, Guo P, Bracht T, Sitek B, Gschwend JE, Xu W, Nawroth R. The mechanism of resistance to CDK4\/6 inhibition and novel combination therapy with RNR inhibition for chemo-resistant bladder cancer. Cancer Commun (lond). 2024;44:700\u201304. https:\/\/doi.org\/10.1002\/cac2.12532","journal-title":"Cancer Commun (lond)"},{"key":"7537_CR44","first-page":"3595","volume":"6","author":"NH Chow","year":"2000","unstructured":"Chow NH, Liu HS, Chan SH. The role of nm23-H1 in the progression of transitional cell bladder cancer. Clin Cancer Res. 2000;6:3595\u201399","journal-title":"Clin Cancer Res"},{"key":"7537_CR45","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1046\/j.1365-2958.1998.00846.x","volume":"28","author":"AM Chakrabarty","year":"1998","unstructured":"Chakrabarty AM. Nucleoside diphosphate kinase: role in bacterial growth, virulence, cell signalling and polysaccharide synthesis. Mol Microbiol. 1998;28:875\u201382. https:\/\/doi.org\/10.1046\/j.1365-2958.1998.00846.x","journal-title":"Mol Microbiol"},{"key":"7537_CR46","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-023-06889-6","volume":"625","author":"MG Cho","year":"2024","unstructured":"Cho MG, Kumar RJ, Lin CC, Boyer JA, Shahir JA, Fagan-Solis K, Simpson DA, Fan C, Foster CE, Goddard AM, Lerner LM, Ellington SW, Wang Q, Wang Y, Ho AY, Liu P, Perou CM, Zhang Q, McGinty RK, Purvis JE, Gupta GP. MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis. Nature. 2024;625:585\u201392. https:\/\/doi.org\/10.1038\/s41586-023-06889-6","journal-title":"Nature"},{"key":"7537_CR47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wu J, Zhai L, Zhang T, Yin H, Gao H, Zhao F, Wang Z, Yang X, Jin M, Huang B, Ding X, Li R, Yang J, He Y, Wang Q, Wang W, Kloeber JA, Li Y, Hao B, Zhang Y, Wang J, Tan M, Li K, Wang P, Lou Z, Yuan J. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 2024;187:294\u2013311.e21. https:\/\/doi.org\/10.1016\/j.cell.2023.11.022","journal-title":"Cell"},{"key":"7537_CR48","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41422-018-0086-7","volume":"28","author":"ST Sizemore","year":"2018","unstructured":"Sizemore ST, Zhang M, Cho JH, Sizemore GM, Hurwitz B, Kaur B, Lehman NL, Ostrowski MC, Robe PA, Miao W, Wang Y, Chakravarti A, Xia F. Pyruvate kinase M2 regulates homologous recombination-mediated DNA double-strand break repair. Cell Res. 2018;28:1090\u2013102. https:\/\/doi.org\/10.1038\/s41422-018-0086-7","journal-title":"Cell Res"},{"key":"7537_CR49","doi-asserted-by":"publisher","first-page":"7972","DOI":"10.1093\/nar\/gkad549","volume":"51","author":"PE Head","year":"2023","unstructured":"Head PE, Kapoor-Vazirani P, Nagaraju GP, Zhang H, Rath SK, Luong NC, Haji-Seyed-Javadi R, Sesay F, Wang SY, Duong DM, Daddacha W, Minten EV, Song B, Danelia D, Liu X, Li S, Ortlund EA, Seyfried NT, Smalley DM, Wang Y, Deng X, Dynan WS, El-Rayes B, Davis AJ, Yu DS. DNA-PK is activated by SIRT2 deacetylation to promote DNA double-strand break repair by non-homologous end joining. Nucleic Acids Res. 2023;51:7972\u201387. https:\/\/doi.org\/10.1093\/nar\/gkad549","journal-title":"Nucleic Acids Res"},{"key":"7537_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12964-015-0114-x","volume":"13","author":"W Wagner","year":"2015","unstructured":"Wagner W, Ciszewski WM, Kania KD. L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation. Cell Commun Signal. 2015;13:36. https:\/\/doi.org\/10.1186\/s12964-015-0114-x","journal-title":"Cell Commun Signal"},{"key":"7537_CR51","doi-asserted-by":"publisher","first-page":"e0136142","DOI":"10.1371\/journal.pone.0136142","volume":"10","author":"M Mushtaq","year":"2015","unstructured":"Mushtaq M, Darekar S, Klein G, Kashuba E. Different mechanisms of regulation of the warburg effect in Lymphoblastoid and Burkitt lymphoma cells. PLoS One. 2015;10:e0136142. https:\/\/doi.org\/10.1371\/journal.pone.0136142","journal-title":"PLoS One"},{"key":"7537_CR52","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.7150\/ijbs.45420","volume":"16","author":"X Zhu","year":"2020","unstructured":"Zhu X, Xuan Z, Chen J, Li Z, Zheng S, Song P. How DNA methylation affects the warburg effect. Int J Biol Sci. 2020;16:2029\u201341. https:\/\/doi.org\/10.7150\/ijbs.45420","journal-title":"Int J Biol Sci"},{"key":"7537_CR53","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13045-022-01358-5","volume":"15","author":"X Zhong","year":"2022","unstructured":"Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao S, Wei P, Li D. Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. J Hematol Oncol. 2022;15:160. https:\/\/doi.org\/10.1186\/s13045-022-01358-5","journal-title":"J Hematol Oncol"},{"key":"7537_CR54","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2014.08.027","volume":"79","author":"X Chen","year":"2015","unstructured":"Chen X, Qian Y, Wu S. The warburg effect: evolving interpretations of an established concept. Free Radic Biol Med. 2015;79:253\u201363. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.08.027","journal-title":"Free Radic Biol Med"},{"key":"7537_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18010179","author":"T Takai","year":"2017","unstructured":"Takai T, Yoshikawa Y, Inamoto T, Minami K, Taniguchi K, Sugito N, Kuranaga Y, Shinohara H, Kumazaki M, Tsujino T, Takahara K, Ito Y, Akao Y, Azuma H. A novel combination RNAi toward warburg effect by replacement with miR-145 and silencing of PTBP1 induces apoptotic cell death in bladder cancer cells. Int J Mol Sci. 2017, 18. https:\/\/doi.org\/10.3390\/ijms18010179","journal-title":"Int J Mol Sci"},{"key":"7537_CR56","doi-asserted-by":"publisher","first-page":"33064","DOI":"10.18632\/oncotarget.16524","volume":"8","author":"K Minami","year":"2017","unstructured":"Minami K, Taniguchi K, Sugito N, Kuranaga Y, Inamoto T, Takahara K, Takai T, Yoshikawa Y, Kiyama S, Akao Y, Azuma H. MiR-145 negatively regulates warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells. Oncotarget. 2017;8:33064\u201377. https:\/\/doi.org\/10.18632\/oncotarget.16524","journal-title":"Oncotarget"},{"key":"7537_CR57","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3892\/or.2015.4536","volume":"35","author":"Y Sun","year":"2016","unstructured":"Sun Y, Guan Z, Liang L, Cheng Y, Zhou J, Li J, Xu Y. HIF-1\u03b1\/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer. Oncol Rep. 2016;35:1549\u201356. https:\/\/doi.org\/10.3892\/or.2015.4536","journal-title":"Oncol Rep"},{"key":"7537_CR58","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7150\/jca.48896","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Zou Y, Pei M, Zhang Y, Jiang Y. Berberine inhibits the Warburg effect through TET3\/miR-145\/HK2 pathways in ovarian cancer cells. J Cancer. 2021;12:207\u201316. https:\/\/doi.org\/10.7150\/jca.48896","journal-title":"J Cancer"},{"key":"7537_CR59","doi-asserted-by":"publisher","unstructured":"Aleksandrov R, Hristova R, Stoynov S, Gospodinov A. The chromatin response to double-strand DNA breaks and their repair. Cells. 2020, 9: https:\/\/doi.org\/10.3390\/cells9081853","DOI":"10.3390\/cells9081853"},{"key":"7537_CR60","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jprot.2017.01.013","volume":"156","author":"B Abbaoui","year":"2017","unstructured":"Abbaoui B, Telu KH, Lucas CR, Thomas-Ahner JM, Schwartz SJ, Clinton SK, Freitas MA, Mortazavi A. The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer. J Proteomics. 2017;156:94\u2013103. https:\/\/doi.org\/10.1016\/j.jprot.2017.01.013","journal-title":"J Proteomics"},{"key":"7537_CR61","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1113\/jp278810","volume":"599","author":"P Vaupel","year":"2021","unstructured":"Vaupel P, Multhoff G. Revisiting the warburg effect: historical dogma versus current understanding. J Physiol. 2021;599:1745\u201357. https:\/\/doi.org\/10.1113\/jp278810","journal-title":"J Physiol"},{"key":"7537_CR62","doi-asserted-by":"publisher","unstructured":"Ler LD, Ghosh S, Chai X, Thike AA, Heng HL, Siew EY, Dey S, Koh LK, Lim JQ, Lim WK, Myint SS, Loh JL, Ong P, Sam XX, Huang D, Lim T, Tan PH, Nagarajan S, Cheng CW, Ho H, Ng LG, Yuen J, Lin PH, Chuang CK, Chang YH, Weng WH, Rozen SG, Tan P, Creasy CL, Pang ST, McCabe MT, Poon SL, Teh BT. Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2. Sci Transl Med. 2017;9. https:\/\/doi.org\/10.1126\/scitranslmed.aai8312","DOI":"10.1126\/scitranslmed.aai8312"},{"key":"7537_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910612","author":"YF Yang","year":"2021","unstructured":"Yang YF, Chuang HW, Kuo WT, Lin BS, Chang YC. Current development and application of anaerobic glycolytic enzymes in urothelial cancer. Int J Mol Sci. 2021, 22. https:\/\/doi.org\/10.3390\/ijms221910612","journal-title":"Int J Mol Sci"},{"key":"7537_CR64","doi-asserted-by":"publisher","first-page":"e2403331121","DOI":"10.1073\/pnas.2403331121","volume":"121","author":"M Pornour","year":"2024","unstructured":"Pornour M, Jeon HY, Ryu H, Khadka S, Xu R, Chen H, Hussain A, Lam HM, Zhuang Z, Oo HZ, Gleave M, Dong X, Wang Q, Barbieri C, Qi J. USP11 promotes prostate cancer progression by up-regulating ar and c-myc activity. Proc Natl Acad Sci U S A. 2024;121:e2403331121. https:\/\/doi.org\/10.1073\/pnas.2403331121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7537_CR65","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41388-023-02932-y","volume":"43","author":"F Zhou","year":"2024","unstructured":"Zhou F, Deng Z, Shen D, Lu M, Li M, Yu J, Xiao Y, Wang G, Qian K, Ju L, Wang X. DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11. Oncogene. 2024;43:594\u2013607. https:\/\/doi.org\/10.1038\/s41388-023-02932-y","journal-title":"Oncogene"},{"key":"7537_CR66","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.7150\/thno.102730","volume":"15","author":"Z Deng","year":"2025","unstructured":"Deng Z, Zhou F, Li M, Jin W, Yu J, Wang G, Qian K, Ju L, Zhang Y, Xiao Y, Wang X. DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through myc stabilization. Theranostics. 2025;15:2375\u201392. https:\/\/doi.org\/10.7150\/thno.102730","journal-title":"Theranostics"},{"key":"7537_CR67","doi-asserted-by":"publisher","first-page":"14133","DOI":"10.18632\/oncotarget.13044","volume":"8","author":"JT Zhong","year":"2017","unstructured":"Zhong JT, Zhou SH. Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma. Oncotarget. 2017;8:14133\u201346. https:\/\/doi.org\/10.18632\/oncotarget.13044","journal-title":"Oncotarget"},{"key":"7537_CR68","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1158\/1078-0432.Ccr-13-1455","volume":"20","author":"Y Fan","year":"2014","unstructured":"Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y. TGF-\u03b2-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res. 2014;20:1531\u201341. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-1455","journal-title":"Clin Cancer Res"},{"key":"7537_CR69","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1039\/c2mb25386k","volume":"9","author":"L Ying","year":"2013","unstructured":"Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y, Liu Y, Qiu F. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst. 2013;9:407\u201311. https:\/\/doi.org\/10.1039\/c2mb25386k","journal-title":"Mol Biosyst"},{"key":"7537_CR70","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2011.354","volume":"31","author":"P Lopez-Serra","year":"2012","unstructured":"Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene. 2012;31:1609\u201322. https:\/\/doi.org\/10.1038\/onc.2011.354","journal-title":"Oncogene"},{"key":"7537_CR71","doi-asserted-by":"publisher","first-page":"15805","DOI":"10.1073\/pnas.0707628104","volume":"104","author":"M Fabbri","year":"2007","unstructured":"Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 2007;104:15805\u201310. https:\/\/doi.org\/10.1073\/pnas.0707628104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7537_CR72","doi-asserted-by":"publisher","unstructured":"Monteiro-Reis S, Lobo J, Henrique R, Jer\u00f3nimo C. Epigenetic mechanisms influencing epithelial to mesenchymal transition in bladder cancer. Int J Mol Sci. 2019;20. https:\/\/doi.org\/10.3390\/ijms20020297","DOI":"10.3390\/ijms20020297"},{"key":"7537_CR73","doi-asserted-by":"publisher","first-page":"19415","DOI":"10.18632\/aging.203353","volume":"13","author":"R Zhou","year":"2021","unstructured":"Zhou R, Liang J, Chen Q, Tian H, Yang C, Liu C. Development and validation of an intra-tumor heterogeneity-related signature to predict prognosis of bladder cancer: a study based on single-cell RNA-seq. Aging. 2021;13:19415\u201341. https:\/\/doi.org\/10.18632\/aging.203353","journal-title":"Aging"},{"key":"7537_CR74","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.21037\/tau.2020.03.13","volume":"9","author":"HW Kang","year":"2020","unstructured":"Kang HW, Kim WJ, Choi W, Yun SJ. Tumor heterogeneity in muscle-invasive bladder cancer. Transl Androl Urol. 2020;9:2866\u201380. https:\/\/doi.org\/10.21037\/tau.2020.03.13","journal-title":"Transl Androl Urol"},{"key":"7537_CR75","doi-asserted-by":"publisher","unstructured":"Li S, Yang K, Jin Z, Yan P, Wei Y, Li J, Xu M, Guo X, Xing Q, Zhang H, Liu Q, Yang X, Liu C. Recent advances in bladder cancer stem cells (BCSCs): a descriptive review of emerging therapeutic targets. iScience. 2025;28:112720. https:\/\/doi.org\/10.1016\/j.isci.2025.112720","DOI":"10.1016\/j.isci.2025.112720"},{"key":"7537_CR76","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1042\/bcj20160613","volume":"473","author":"K Nam","year":"2016","unstructured":"Nam K, Oh S, Shin I. Ablation of CD44 induces glycolysis-to-oxidative phosphorylation transition via modulation of the c-src-akt-LKB1-AMPK\u03b1 pathway. Biochemical J. 2016;473:3013\u201330. https:\/\/doi.org\/10.1042\/bcj20160613","journal-title":"Biochemical J"},{"key":"7537_CR77","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1038\/sj.emboj.7601291","volume":"25","author":"JH Park","year":"2006","unstructured":"Park JH, Park EJ, Lee HS, Kim SJ, Hur SK, Imbalzano AN, Kwon J. Mammalian SWI\/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. Embo J. 2006;25:3986\u201397. https:\/\/doi.org\/10.1038\/sj.emboj.7601291","journal-title":"Embo J"},{"key":"7537_CR78","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41467-021-21535-3","volume":"12","author":"F Zheng","year":"2021","unstructured":"Zheng F, Chen J, Zhang X, Wang Z, Chen J, Lin X, Huang H, Fu W, Liang J, Wu W, Li B, Yao H, Hu H, Song E. The HIF-1\u03b1 antisense long non-coding rna drives a positive feedback loop of HIF-1\u03b1 mediated transactivation and glycolysis. Nat Commun. 2021;12:1341. https:\/\/doi.org\/10.1038\/s41467-021-21535-3","journal-title":"Nat Commun"},{"key":"7537_CR79","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/sj.bjc.6601260","volume":"89","author":"PJ Hoskin","year":"2003","unstructured":"Hoskin PJ, Sibtain A, Daley FM, Wilson GD. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer. 2003;89:1290\u201397. https:\/\/doi.org\/10.1038\/sj.bjc.6601260","journal-title":"Br J Cancer"},{"key":"7537_CR80","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1038\/onc.2017.13","volume":"36","author":"W Wan","year":"2017","unstructured":"Wan W, Peng K, Li M, Qin L, Tong Z, Yan J, Shen B, Yu C. Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1\u03b1. Oncogene. 2017;36:3868\u201377. https:\/\/doi.org\/10.1038\/onc.2017.13","journal-title":"Oncogene"},{"key":"7537_CR81","doi-asserted-by":"publisher","unstructured":"Cunha A, Silva PMA, Sarmento B, Queir\u00f3s O. Targeting glucose metabolism in cancer cells as an approach to overcoming drug resistance. Pharmaceutics. 2023, 15: https:\/\/doi.org\/10.3390\/pharmaceutics15112610","DOI":"10.3390\/pharmaceutics15112610"},{"key":"7537_CR82","doi-asserted-by":"publisher","first-page":"7714","DOI":"10.1038\/s41598-020-64880-x","volume":"10","author":"F Duan","year":"2020","unstructured":"Duan F, Mei C, Yang L, Zheng J, Lu H, Xia Y, Hsu S, Liang H, Hong L. Vitamin K2 promotes PI3K\/AKT\/HIF-1\u03b1-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells. Sci Rep. 2020;10:7714. https:\/\/doi.org\/10.1038\/s41598-020-64880-x","journal-title":"Sci Rep"},{"key":"7537_CR83","doi-asserted-by":"publisher","unstructured":"Li Y, Kang J, Fu J, Luo H, Liu Y, Li Y, Sun L. PGC1\u03b1 promotes cisplatin resistance in ovarian cancer by regulating the HSP70\/HK2\/VDAC1 signaling pathway. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms22052537","DOI":"10.3390\/ijms22052537"},{"key":"7537_CR84","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/ott.S358008","volume":"15","author":"M Li","year":"2022","unstructured":"Li M, Che N, Jin Y, Li J, Yang W. CDKN3 overcomes bladder cancer cisplatin resistance via LDHA-Dependent glycolysis reprogramming. oncotargets And Ther. 2022;15:299\u2013311. https:\/\/doi.org\/10.2147\/ott.S358008","journal-title":"oncotargets And Ther"},{"key":"7537_CR85","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s13402-023-00826-5","volume":"46","author":"L Pei","year":"2023","unstructured":"Pei L, Yan D, He Q, Kong J, Yang M, Ruan H, Lin Q, Huang L, Huang J, Lin T, Qin H. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder. Cell Oncol (Dordr). 2023;46:1509\u201327. https:\/\/doi.org\/10.1007\/s13402-023-00826-5","journal-title":"Cell Oncol (Dordr)"},{"key":"7537_CR86","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s13238-017-0442-2","volume":"9","author":"RR Wang","year":"2018","unstructured":"Wang RR, Pan R, Zhang W, Fu J, Lin JD, Meng ZX. The SWI\/SNF chromatin-remodeling factors BAF60a, b, and c in nutrient signaling and metabolic control. Protein Cell. 2018;9:207\u201315. https:\/\/doi.org\/10.1007\/s13238-017-0442-2","journal-title":"Protein Cell"},{"key":"7537_CR87","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","volume":"593","author":"BI Reinfeld","year":"2021","unstructured":"Reinfeld BI, Madden MZ, Wolf MM, Chytil A, Bader JE, Patterson AR, Sugiura A, Cohen AS, Ali A, Do BT, Muir A, Lewis CA, Hongo RA, Young KL, Brown RE, Todd VM, Huffstater T, Abraham A, O\u2019Neil RT, Wilson MH, Xin F, Tantawy MN, Merryman WD, Johnson RW, Williams CS, Mason EF, Mason FM, Beckermann KE, Heiden MGV, Manning HC, Rathmell JC, Rathmell WK. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature. 2021;593:282\u201388. https:\/\/doi.org\/10.1038\/s41586-021-03442-1","journal-title":"Nature"},{"key":"7537_CR88","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang CH, Qiu J, O\u2019Sullivan D, Buck MD, Noguchi T, Curtis JD, Chen Q, Gindin M, Gubin MM, van der Windt GJ, Tonc E, Schreiber RD, Pearce EJ, Pearce EL. Metabolic competition in the tumor microenvironment is a Driver of cancer progression. Cell. 2015;162:1229\u201341. https:\/\/doi.org\/10.1016\/j.cell.2015.08.016","journal-title":"Cell"},{"key":"7537_CR89","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-immunol-042617-053019","volume":"36","author":"RIK Geltink","year":"2018","unstructured":"Geltink RIK, Kyle RL, Pearce EL. Unraveling the complex interplay between T cell metabolism and function. Annu Rev Immunol. 2018;36:461\u201388. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053019","journal-title":"Annu Rev Immunol"},{"key":"7537_CR90","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner EN, Rathmell JC. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell. 2023;41:421\u201333. https:\/\/doi.org\/10.1016\/j.ccell.2023.01.009","journal-title":"Cancer Cell"},{"key":"7537_CR91","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, Kamada T, Irie T, Okumura G, Kono H, Ito D, Fujii R, Watanabe S, Sai A, Fukuoka S, Sugiyama E, Watanabe G, Owari T, Nishinakamura H, Sugiyama D, Maeda Y, Kawazoe A, Yukami H, Chida K, Ohara Y, Yoshida T, Shinno Y, Takeyasu Y, Shirasawa M, Nakama K, Aokage K, Suzuki J, Ishii G, Kuwata T, Sakamoto N, Kawazu M, Ueno T, Mori T, Yamazaki N, Tsuboi M, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40:201\u201318.e9. https:\/\/doi.org\/10.1016\/j.ccell.2022.01.001","journal-title":"Cancer Cell"},{"key":"7537_CR92","doi-asserted-by":"publisher","first-page":"8658","DOI":"10.1038\/s41467-024-52666-y","volume":"15","author":"JA Guerrero","year":"2024","unstructured":"Guerrero JA, Klysz DD, Chen Y, Malipatlolla M, Lone J, Fowler C, Stuani L, May A, Bashti M, Xu P, Huang J, Michael B, Contrepois K, Dhingra S, Fisher C, Svensson KJ, Davis KL, Kasowski M, Feldman SA, Sotillo E, Mackall CL. GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency. Nat Commun. 2024;15:8658. https:\/\/doi.org\/10.1038\/s41467-024-52666-y","journal-title":"Nat Commun"},{"key":"7537_CR93","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.1038\/s41467-023-41016-z","volume":"14","author":"S Inamdar","year":"2023","unstructured":"Inamdar S, Suresh AP, Mangal JL, Ng ND, Sundem A, Wu C, Lintecum K, Thumsi A, Khodaei T, Halim M, Appel N, Jaggarapu M, Esrafili A, Yaron JR, Curtis M, Acharya AP. Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice. Nat Commun. 2023;14:5333. https:\/\/doi.org\/10.1038\/s41467-023-41016-z","journal-title":"Nat Commun"},{"key":"7537_CR94","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","volume":"34","author":"D Guo","year":"2022","unstructured":"Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, Wu Q, Li S, Luo S, Li M, Xiao L, He H, He X, Yu Q, Fang J, Lu Z. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1. Cell Metab. 2022;34:1312\u201324.e6. https:\/\/doi.org\/10.1016\/j.cmet.2022.08.002","journal-title":"Cell Metab"},{"key":"7537_CR95","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1158\/1078-0432.Ccr-08-0731","volume":"14","author":"SA Boorjian","year":"2008","unstructured":"Boorjian SA, Sheinin Y, Crispen PL, Farmer SA, Lohse CM, Kuntz SM, Leibovich BC, Kwon ED, Frank I. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. Clin Cancer Res. 2008;14:4800\u201308. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-0731","journal-title":"Clin Cancer Res"},{"key":"7537_CR96","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/cncr.22588","volume":"109","author":"BA Inman","year":"2007","unstructured":"Inman BA, Sebo TJ, Frigola X, Dong H, Bergstralh EJ, Frank I, Fradet Y, Lacombe L, Kwon ED. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer. 2007;109:1499\u2013505. https:\/\/doi.org\/10.1002\/cncr.22588","journal-title":"Cancer"},{"key":"7537_CR97","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJMoa2002788","volume":"383","author":"T Powles","year":"2020","unstructured":"Powles T, Park SH, Voog E, Caserta C, Valderrama BP, Gurney H, Kalofonos H, Radulovi\u0107 S, Demey W, Ull\u00e9n A, Loriot Y, Sridhar SS, Tsuchiya N, Kopyltsov E, Sternberg CN, Bellmunt J, Aragon-Ching JB, Petrylak DP, Laliberte R, Wang J, Huang B, Davis C, Fowst C, Costa N, Blake-Haskins JA, di Pietro A, Grivas P. Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma. N Engl J Med. 2020;383:1218\u201330. https:\/\/doi.org\/10.1056\/NEJMoa2002788","journal-title":"N Engl J Med"},{"key":"7537_CR98","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu L, Jin Y, Zhao X, Tang K, Zhao Y, Tong L, Yu X, Xiong K, Luo C, Zhu J, Wang F, Zeng Z, Pan D. Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1. Cell Metab. 2023;35:1580\u201396.e9. https:\/\/doi.org\/10.1016\/j.cmet.2023.07.001","journal-title":"Cell Metab"},{"key":"7537_CR99","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","volume":"28","author":"W Li","year":"2018","unstructured":"Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L, Wen B, Shu P, Sun D, Kleer C, Wicha M, Sabel M, Tao K, Wang G, Zou W. Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB Isoform in triple-negative breast cancer. Cell Metab. 2018;28:87\u2013103.e6. https:\/\/doi.org\/10.1016\/j.cmet.2018.04.022","journal-title":"Cell Metab"},{"key":"7537_CR100","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","volume":"27","author":"T Cascone","year":"2018","unstructured":"Cascone T, McKenzie JA, Mbofung RM, Punt S, Wang Z, Xu C, Williams LJ, Wang Z, Bristow CA, Carugo A, Peoples MD, Li L, Karpinets T, Huang L, Malu S, Creasy C, Leahey SE, Chen J, Chen Y, Pelicano H, Bernatchez C, Gopal YNV, Heffernan TP, Hu J, Wang J, Amaria RN, Garraway LA, Huang P, Yang P, Wistuba SEW II, Roszik J, Davis RE, Davies MA, Heymach JV, Hwu P, Peng W. Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy. Cell Metab. 2018;27:977\u201387.e4. https:\/\/doi.org\/10.1016\/j.cmet.2018.02.024","journal-title":"Cell Metab"},{"key":"7537_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042153","author":"AM Perevalova","year":"2024","unstructured":"Perevalova AM, Gulyaeva LF, Pustylnyak VO. Roles of interferon regulatory Factor 1 in tumor progression and regression: two sides of a coin. Int J Mol Sci. 2024, 25. https:\/\/doi.org\/10.3390\/ijms25042153","journal-title":"Int J Mol Sci"},{"key":"7537_CR102","doi-asserted-by":"publisher","first-page":"9877","DOI":"10.1007\/s00432-023-04902-z","volume":"149","author":"J Lin","year":"2023","unstructured":"Lin J, Ding M, Qin C, Song Y, Yang W, Du Y, Xu T. A robust gene prognostic index composed of GZMB, IRF1, and TP63 can stratify the risk of two metastatic urothelial carcinoma cohorts based on immune checkpoint blockade therapy. J Cancer Res And Clin Oncol. 2023;149:9877\u201390. https:\/\/doi.org\/10.1007\/s00432-023-04902-z","journal-title":"J Cancer Res And Clin Oncol"},{"key":"7537_CR103","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12672-024-00982-6","volume":"15","author":"T Yin","year":"2024","unstructured":"Yin T, Mou S, Zhang H, Dong Y, Yan B, Huang W, Liu Y, Mei H. CXCL10 could be a prognostic and immunological biomarker in bladder cancer. Discov Oncol. 2024;15:148. https:\/\/doi.org\/10.1007\/s12672-024-00982-6","journal-title":"Discov Oncol"},{"key":"7537_CR104","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12967-025-06138-6","volume":"23","author":"J Li","year":"2025","unstructured":"Li J, Jiang Y, Ma M, Wang L, Jing M, Yang Z, Zhang M, Chen K, Fan J. Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics. J Transl Med. 2025;23:135. https:\/\/doi.org\/10.1186\/s12967-025-06138-6","journal-title":"J Transl Med"},{"key":"7537_CR105","doi-asserted-by":"publisher","first-page":"216964","DOI":"10.1016\/j.canlet.2024.216964","volume":"593","author":"Y Yu","year":"2024","unstructured":"Yu Y, Liang Y, Xie F, Zhang Z, Zhang P, Zhao X, Zhang Z, Liang Z, Li D, Wang L, Chen Y, Sun L, Niu H, Wang Y. Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation. Cancer Lett. 2024;593:216964. https:\/\/doi.org\/10.1016\/j.canlet.2024.216964","journal-title":"Cancer Lett"},{"key":"7537_CR106","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.ccell.2022.08.010","volume":"40","author":"M Wang","year":"2022","unstructured":"Wang M, Chen X, Tan P, Wang Y, Pan X, Lin T, Jiang Y, Wang B, Xu H, Wang Y, Yang Y, Wang J, Zhao L, Zhang J, Zhong A, Peng Y, Du J, Zhang Q, Zheng J, Chen J, Dai S, Na F, Lu Z, Liu J, Zheng X, Yang L, Zhang P, Han P, Gong Q, Zhong Q, Xiao K, Yang H, Deng H, Zhao Y, Shi H, Man J, Gou M, Zhao C, Dai L, Xue Z, et al. Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer. Cancer Cell. 2022;40:1044\u201359.e8. https:\/\/doi.org\/10.1016\/j.ccell.2022.08.010","journal-title":"Cancer Cell"},{"key":"7537_CR107","doi-asserted-by":"publisher","unstructured":"Petrella G, Ciufolini G, Vago R, Cicero DO. Urinary metabolic markers of bladder cancer: a reflection of the tumor or the response of the body? Metabolites. 2021; 11: https:\/\/doi.org\/10.3390\/metabo11110756","DOI":"10.3390\/metabo11110756"},{"key":"7537_CR108","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","volume":"25","author":"RM Peralta","year":"2024","unstructured":"Peralta RM, Xie B, Lontos K, Nieves-Rosado H, Spahr K, Joshi S, Ford BR, Quann K, Frisch AT, Dean V, Philbin M, Cillo AR, Gingras S, Poholek AC, Kane LP, Rivadeneira DB, Delgoffe GM. Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism. Nat Immunol. 2024;25:2297\u2013307. https:\/\/doi.org\/10.1038\/s41590-024-01999-3","journal-title":"Nat Immunol"},{"key":"7537_CR109","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1172\/jci69589","volume":"123","author":"M Sukumar","year":"2013","unstructured":"Sukumar M, Liu J, Ji Y, Subramanian M, Crompton JG, Yu Z, Roychoudhuri R, Palmer DC, Muranski P, Karoly ED, Mohney RP, Klebanoff CA, Lal A, Finkel T, Restifo NP, Gattinoni L. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J Clin Invest. 2013;123:4479\u201388. https:\/\/doi.org\/10.1172\/jci69589","journal-title":"J Clin Invest"},{"key":"7537_CR110","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, Menk AV, Rittenhouse NL, DePeaux K, Whetstone RD, Vignali DAA, Hand TW, Poholek AC, Morrison BM, Rothstein JD, Wendell SG, Delgoffe GM. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591:645\u201351. https:\/\/doi.org\/10.1038\/s41586-020-03045-2","journal-title":"Nature"},{"key":"7537_CR111","doi-asserted-by":"publisher","first-page":"114119","DOI":"10.1016\/j.intimp.2025.114119","volume":"148","author":"X Deng","year":"2025","unstructured":"Deng X, Huang Y, Zhang J, Chen Y, Jiang F, Zhang Z, Li T, Hou L, Tan W, Li F. Histone lactylation regulates PRKN-Mediated mitophagy to promote M2 macrophage polarization in bladder cancer. Int Immunopharmacol. 2025;148:114119. https:\/\/doi.org\/10.1016\/j.intimp.2025.114119","journal-title":"Int Immunopharmacol"},{"key":"7537_CR112","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, Ding J, Czyz D, Hu R, Ye Z, He M, Zheng YG, Shuman HA, Dai L, Ren B, Roeder RG, Becker L, Zhao Y. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1678-1","journal-title":"Nature"},{"key":"7537_CR113","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.gendis.2022.10.006","volume":"10","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Peng Q, Zheng J, Yang Y, Zhang X, Ma A, Qin Y, Qin Z, Zheng X. The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment. Genes Dis. 2023;10:2029\u201337. https:\/\/doi.org\/10.1016\/j.gendis.2022.10.006","journal-title":"Genes Dis"},{"key":"7537_CR114","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41586-023-06409-6","volume":"620","author":"LM Sanmarco","year":"2023","unstructured":"Sanmarco LM, Rone JM, Polonio CM, Lahore GF, Giovannoni F, Ferrara K, Gutierrez-Vazquez C, Li N, Sokolovska A, Plasencia A, Akl CF, Nanda P, Heck ES, Li Z, Lee HG, Chao CC, Rejano-Gordillo CM, Fonseca-Castro PH, Illouz T, Linnerbauer M, Kenison JE, Barilla RM, Farrenkopf D, Stevens NA, Piester G, Chung EN, Dailey L, Kuchroo VK, Hava D, Wheeler MA, Clish C, Nowarski R, Balsa E, Lora JM, Quintana FJ. Lactate limits CNS autoimmunity by stabilizing HIF-1\u03b1 in dendritic cells. Nature. 2023;620:881\u201389. https:\/\/doi.org\/10.1038\/s41586-023-06409-6","journal-title":"Nature"},{"key":"7537_CR115","doi-asserted-by":"publisher","first-page":"e26744","DOI":"10.4161\/onci.26744","volume":"2","author":"A Nasi","year":"2013","unstructured":"Nasi A, Rethi B. Disarmed by density: a glycolytic break for immunostimulatory dendritic cells? Oncoimmunology. 2013;2:e26744. https:\/\/doi.org\/10.4161\/onci.26744","journal-title":"Oncoimmunology"},{"key":"7537_CR116","doi-asserted-by":"publisher","first-page":"216837","DOI":"10.1016\/j.canlet.2024.216837","volume":"590","author":"S Chen","year":"2024","unstructured":"Chen S, Xu Y, Zhuo W, Zhang L. The emerging role of lactate in tumor microenvironment and its clinical relevance. Cancer Lett. 2024;590:216837. https:\/\/doi.org\/10.1016\/j.canlet.2024.216837","journal-title":"Cancer Lett"},{"key":"7537_CR117","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41590-025-02178-8","volume":"26","author":"J Jin","year":"2025","unstructured":"Jin J, Yan P, Wang D, Bai L, Liang H, Zhu X, Zhu H, Ding C, Wei H, Wang Y. Targeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment. Nat Immunol. 2025;26:1099\u2013112. https:\/\/doi.org\/10.1038\/s41590-025-02178-8","journal-title":"Nat Immunol"},{"key":"7537_CR118","doi-asserted-by":"publisher","first-page":"901495","DOI":"10.3389\/fendo.2022.901495","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhai Z, Duan J, Wang X, Zhong J, Wu L, Li A, Cao M, Wu Y, Shi H, Zhong J, Guo Z. Lactate: the Mediator of metabolism and immunosuppression. Front Endocrinol. 2022;13:901495. https:\/\/doi.org\/10.3389\/fendo.2022.901495","journal-title":"Front Endocrinol"},{"key":"7537_CR119","doi-asserted-by":"publisher","first-page":"e2303230","DOI":"10.1002\/advs.202303230","volume":"10","author":"T Liang","year":"2023","unstructured":"Liang T, Tao T, Wu K, Liu L, Xu W, Zhou D, Fang H, Ding Q, Huang G, Wu S. Cancer-associated fibroblast-induced remodeling of tumor microenvironment in recurrent bladder cancer. Adv Sci (Weinh). 2023;10:e2303230. https:\/\/doi.org\/10.1002\/advs.202303230","journal-title":"Adv Sci (Weinh)"},{"key":"7537_CR120","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s11427-020-1887-7","volume":"64","author":"J Wen","year":"2021","unstructured":"Wen J, Cheng S, Zhang Y, Wang R, Xu J, Ling Z, Ma L, Ai X, Sun B. Lactate anions participate in T cell cytokine production and function. Sci China Life Sci. 2021;64:1895\u2013905. https:\/\/doi.org\/10.1007\/s11427-020-1887-7","journal-title":"Sci China Life Sci"},{"key":"7537_CR121","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","volume":"13","author":"Q Feng","year":"2022","unstructured":"Feng Q, Liu Z, Yu X, Huang T, Chen J, Wang J, Wilhelm J, Li S, Song J, Li W, Sun Z, Sumer BD, Li B, Fu YX, Gao J. Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity. Nat Commun. 2022;13:4981. https:\/\/doi.org\/10.1038\/s41467-022-32521-8","journal-title":"Nat Commun"},{"key":"7537_CR122","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s42255-022-00730-6","volume":"5","author":"H Cheng","year":"2023","unstructured":"Cheng H, Qiu Y, Xu Y, Chen L, Ma K, Tao M, Frankiw L, Yin H, Xie E, Pan X, Du J, Wang Z, Zhu W, Chen L, Zhang L, Li G. Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness. Nat Metab. 2023;5:314\u201330. https:\/\/doi.org\/10.1038\/s42255-022-00730-6","journal-title":"Nat Metab"},{"key":"7537_CR123","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","volume":"58","author":"A Llibre","year":"2025","unstructured":"Llibre A, Kucuk S, Gope A, Certo M, Mauro C. Lactate: a key regulator of the immune response. Immunity. 2025;58:535\u201354. https:\/\/doi.org\/10.1016\/j.immuni.2025.02.008","journal-title":"Immunity"},{"key":"7537_CR124","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41576-023-00601-0","volume":"24","author":"J Haerinck","year":"2023","unstructured":"Haerinck J, Goossens S, Berx G. The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation. Nat Rev Genet. 2023;24:590\u2013609. https:\/\/doi.org\/10.1038\/s41576-023-00601-0","journal-title":"Nat Rev Genet"},{"key":"7537_CR125","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neo.2020.12.009","volume":"23","author":"F Marcucci","year":"2021","unstructured":"Marcucci F, Rumio C. Glycolysis-induced drug resistance in tumors-A response to danger signals? Neoplasia. 2021;23:234\u201345. https:\/\/doi.org\/10.1016\/j.neo.2020.12.009","journal-title":"Neoplasia"},{"key":"7537_CR126","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10555-009-9194-7","volume":"28","author":"DJ McConkey","year":"2009","unstructured":"McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, Siefker-Radtke A, Dinney C. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev. 2009;28:335\u201344. https:\/\/doi.org\/10.1007\/s10555-009-9194-7","journal-title":"Cancer Metastasis Rev"},{"key":"7537_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/cells11061041","author":"F Marcucci","year":"2022","unstructured":"Marcucci F, Rumio C. Tumor cell glycolysis-at the crossroad of epithelial-mesenchymal transition and autophagy. Cells. 2022, 11. https:\/\/doi.org\/10.3390\/cells11061041","journal-title":"Cells"},{"key":"7537_CR128","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, Yao Y, Xu S, Ge S, Jia R. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10:38. https:\/\/doi.org\/10.1038\/s41392-024-02082-x","journal-title":"Signal Transduct Target Ther"},{"key":"7537_CR129","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13046-023-02688-z","volume":"42","author":"L Long","year":"2023","unstructured":"Long L, Xiong W, Lin F, Hou J, Chen G, Peng T, He Y, Wang R, Xu Q, Huang Y. Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery. J Exp Clin Cancer Res. 2023;42:117. https:\/\/doi.org\/10.1186\/s13046-023-02688-z","journal-title":"J Exp Clin Cancer Res"},{"key":"7537_CR130","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41467-022-28440-3","volume":"13","author":"CS Blaha","year":"2022","unstructured":"Blaha CS, Ramakrishnan G, Jeon SM, Nogueira V, Rho H, Kang S, Bhaskar P, Terry AR, Aissa AF, Frolov MV, Patra KC, Robey RB, Hay N. A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis. Nat Commun. 2022;13:899. https:\/\/doi.org\/10.1038\/s41467-022-28440-3","journal-title":"Nat Commun"},{"key":"7537_CR131","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","volume":"86","author":"S Paul","year":"2022","unstructured":"Paul S, Ghosh S, Kumar S. Tumor glycolysis, an essential sweet tooth of tumor cells. Semin Cancer Biol. 2022;86:1216\u201330. https:\/\/doi.org\/10.1016\/j.semcancer.2022.09.007","journal-title":"Semin Cancer Biol"},{"key":"7537_CR132","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3892\/mmr.2019.10466","volume":"20","author":"SY Lee","year":"2019","unstructured":"Lee SY, Ju MK, Jeon HM, Lee YJ, Kim CH, Park HG, Han SI, Kang HS. Reactive oxygen species induce epithelial\u2011mesenchymal transition, glycolytic switch, and mitochondrial repression through the Dlx\u20112\/Snail signaling pathways in MCF\u20117 cells. Mol Med Rep. 2019;20:2339\u201346. https:\/\/doi.org\/10.3892\/mmr.2019.10466","journal-title":"Mol Med Rep"},{"key":"7537_CR133","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.21037\/jgo-20-474","volume":"11","author":"G Cui","year":"2020","unstructured":"Cui G, Huang Y, Feng W, Yao Y, Zhou H, Li X, Gong H, Liu J, Luo Y, Sun Y, Zhang M, Luo Y, Zhang T. Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo. J Gastrointest Oncol. 2020;11:1164\u201385. https:\/\/doi.org\/10.21037\/jgo-20-474","journal-title":"J Gastrointest Oncol"},{"key":"7537_CR134","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:70. https:\/\/doi.org\/10.1038\/s41392-023-01332-8","journal-title":"Signal Transduct Target Ther"},{"key":"7537_CR135","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","volume":"4","author":"A P\u00e9rez-Gonz\u00e1lez","year":"2023","unstructured":"P\u00e9rez-Gonz\u00e1lez A, B\u00e9vant K, Blanpain C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat Cancer. 2023;4:1063\u201382. https:\/\/doi.org\/10.1038\/s43018-023-00595-y","journal-title":"Nat Cancer"},{"key":"7537_CR136","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","volume":"16","author":"HR Jin","year":"2023","unstructured":"Jin HR, Wang J, Wang ZJ, Xi MJ, Xia BH, Deng K, Yang JL. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol. 2023;16:103. https:\/\/doi.org\/10.1186\/s13045-023-01498-2","journal-title":"J Hematol Oncol"},{"key":"7537_CR137","doi-asserted-by":"publisher","first-page":"e110031","DOI":"10.15252\/embj.2021110031","volume":"41","author":"RC Russell","year":"2022","unstructured":"Russell RC, Guan KL. The multifaceted role of autophagy in cancer. Embo J. 2022;41:e110031. https:\/\/doi.org\/10.15252\/embj.2021110031","journal-title":"Embo J"},{"key":"7537_CR138","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560\u201375. https:\/\/doi.org\/10.1038\/s41580-023-00585-z","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7537_CR139","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1038\/s41467-024-46735-5","volume":"15","author":"M Cheng","year":"2024","unstructured":"Cheng M, Chen S, Li K, Wang G, Xiong G, Ling R, Zhang C, Zhang Z, Han H, Chen Z, Wang X, Liang Y, Tian G, Zhou R, Zhu Y, Ma J, Liu J, Lin S, Xu H, Chen D, Li Y, Peng L. CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer. Nat Commun. 2024;15:2818. https:\/\/doi.org\/10.1038\/s41467-024-46735-5","journal-title":"Nat Commun"},{"key":"7537_CR140","doi-asserted-by":"publisher","unstructured":"Sun Y, Liu X, Tong H, Yin H, Li T, Zhu J, Chen J, Wu L, Zhang X, Gou X, He W. SIRT1 promotes cisplatin resistance in bladder cancer via Beclin1 deacetylation-mediated autophagy. Cancers (Basel). 2023;16. https:\/\/doi.org\/10.3390\/cancers16010125","DOI":"10.3390\/cancers16010125"},{"key":"7537_CR141","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.molcel.2013.12.019","volume":"53","author":"DJ Roberts","year":"2014","unstructured":"Roberts DJ, Tan-Sah VP, Ding EY, Smith JM, Miyamoto S. Hexokinase-II positively regulates glucose starvation-induced autophagy through TORC1 inhibition. Mol Cell. 2014;53:521\u201333. https:\/\/doi.org\/10.1016\/j.molcel.2013.12.019","journal-title":"Mol Cell"},{"key":"7537_CR142","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1074\/mcp.RA119.001576","volume":"18","author":"X Liu","year":"2019","unstructured":"Liu X, Miao W, Huang M, Li L, Dai X, Wang Y. Elevated hexokinase ii expression confers acquired resistance to 4-hydroxytamoxifen in breast cancer cells. Mol Cellular Proteomics. 2019;18:2273\u201384. https:\/\/doi.org\/10.1074\/mcp.RA119.001576","journal-title":"Mol Cellular Proteomics"},{"key":"7537_CR143","doi-asserted-by":"publisher","first-page":"882","DOI":"10.7150\/ijbs.30290","volume":"15","author":"L Wang","year":"2019","unstructured":"Wang L, Yang L, Yang Z, Tang Y, Tao Y, Zhan Q, Lei L, Jing Y, Jiang X, Jin H, Zou Q, Xian J, Zhang L. Glycolytic enzyme PKM2 mediates Autophagic activation to promote cell survival in NPM1-mutated leukemia. Int J Biol Sci. 2019;15:882\u201394. https:\/\/doi.org\/10.7150\/ijbs.30290","journal-title":"Int J Biol Sci"},{"key":"7537_CR144","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.molcel.2015.10.037","volume":"60","author":"C Chang","year":"2015","unstructured":"Chang C, Su H, Zhang D, Wang Y, Shen Q, Liu B, Huang R, Zhou T, Peng C, Wong CC, Shen HM, Lippincott-Schwartz J, Liu W. AMPK-Dependent phosphorylation of GAPDH triggers Sirt1 activation and is necessary for autophagy upon glucose starvation. Mol Cell. 2015;60:930\u201340. https:\/\/doi.org\/10.1016\/j.molcel.2015.10.037","journal-title":"Mol Cell"},{"key":"7537_CR145","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41419-019-1844-2","volume":"10","author":"P Jin","year":"2019","unstructured":"Jin P, Jiang J, Xie N, Zhou L, Huang Z, Zhang L, Qin S, Fu S, Peng L, Gao W, Li B, Lei Y, Nice EC, Li C, Shao J, Xie K. MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1\/AMPK signaling. Cell Death Dis. 2019;10:615. https:\/\/doi.org\/10.1038\/s41419-019-1844-2","journal-title":"Cell Death Dis"},{"key":"7537_CR146","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1080\/15548627.2023.2246356","volume":"19","author":"W Sun","year":"2023","unstructured":"Sun W, Jia M, Feng Y, Cheng X. Lactate is a bridge linking glycolysis and autophagy through lactylation. Autophagy. 2023;19:3240\u201341. https:\/\/doi.org\/10.1080\/15548627.2023.2246356","journal-title":"Autophagy"},{"key":"7537_CR147","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, Xu Y, He J, Lan J, Ou Q, Fang Y, Lu Z, Wu X, Pan Z, Peng J, Lin J. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20:114\u201330. https:\/\/doi.org\/10.1080\/15548627.2023.2249762","journal-title":"Autophagy"},{"key":"7537_CR148","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1038\/s41467-019-11640-9","volume":"10","author":"ALB Flynn","year":"2019","unstructured":"Flynn ALB, Calhoun BC, Sharma A, Chang JC, Almasan A, Schiemann WP. Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression. Nat Commun. 2019;10:3668. https:\/\/doi.org\/10.1038\/s41467-019-11640-9","journal-title":"Nat Commun"},{"key":"7537_CR149","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1038\/s41598-017-03031-1","volume":"7","author":"C Wang","year":"2017","unstructured":"Wang C, Jiang J, Ji J, Cai Q, Chen X, Yu Y, Zhu Z, Zhang J. PKM2 promotes cell migration and inhibits autophagy by mediating PI3K\/AKT activation and contributes to the malignant development of gastric cancer. Sci Rep. 2017;7:2886. https:\/\/doi.org\/10.1038\/s41598-017-03031-1","journal-title":"Sci Rep"},{"key":"7537_CR150","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.bbamcr.2012.10.028","volume":"1833","author":"I Dando","year":"2013","unstructured":"Dando I, Fiorini C, Pozza ED, Padroni C, Costanzo C, Palmieri M, Donadelli M. UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells. Biochim et Biophys Acta. 2013;1833:672\u201379. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.10.028","journal-title":"Biochim et Biophys Acta"},{"key":"7537_CR151","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1111\/jcmm.17943","volume":"27","author":"S Li","year":"2023","unstructured":"Li S, Ruan B, Wang Z, Xia J, Lin Q, Xu R, Zhu H, Yu Z. Glucose dysregulation promotes oncogenesis in human bladder cancer by regulating autophagy and YAP1\/TAZ expression. J Cellular And Mol Med. 2023;27:3744\u201359. https:\/\/doi.org\/10.1111\/jcmm.17943","journal-title":"J Cellular And Mol Med"},{"key":"7537_CR152","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev: Mol Cell Biol. 2018;19:121\u201335. https:\/\/doi.org\/10.1038\/nrm.2017.95","journal-title":"Nat Rev: Mol Cell Biol"},{"key":"7537_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093233","author":"K Bukowski","year":"2020","unstructured":"Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020, 21. https:\/\/doi.org\/10.3390\/ijms21093233","journal-title":"Int J Mol Sci"},{"key":"7537_CR154","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/01.ju.0000074710.96154.c9","volume":"170","author":"JE Diestra","year":"2003","unstructured":"Diestra JE, Condom E, Muro XGD, Scheffer GL, P\u00e9rez J, Zurita AJ, Mu\u00f1oz-Segu\u00ed J, Vigu\u00e9s F, Scheper RJ, Capell\u00e1 G, Germ\u00e0-Lluch JR, Izquierdo MA. Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications. J Urol. 2003;170:1383\u201387. https:\/\/doi.org\/10.1097\/01.ju.0000074710.96154.c9","journal-title":"J Urol"},{"key":"7537_CR155","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.tcb.2022.02.003","volume":"32","author":"X Bian","year":"2022","unstructured":"Bian X, Jiang H, Meng Y, Li YP, Fang J, Lu Z. Regulation of gene expression by glycolytic and gluconeogenic enzymes. Trends Cell Biol. 2022;32:786\u201399. https:\/\/doi.org\/10.1016\/j.tcb.2022.02.003","journal-title":"Trends Cell Biol"},{"key":"7537_CR156","doi-asserted-by":"publisher","first-page":"117452","DOI":"10.1016\/j.biopha.2024.117452","volume":"180","author":"TY Lin","year":"2024","unstructured":"Lin TY, Gu SY, Lin YH, Shih JH, Lin JH, Chou TY, Lee YC, Chang SF, Lang YD. Paclitaxel-resistance facilitates glycolytic metabolism via hexokinase-2-regulated ABC and SLC transporter genes in ovarian clear cell carcinoma. Biomed Pharmacother. 2024;180:117452. https:\/\/doi.org\/10.1016\/j.biopha.2024.117452","journal-title":"Biomed Pharmacother"},{"key":"7537_CR157","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.1007\/s13277-015-4703-5","volume":"37","author":"X Liu","year":"2016","unstructured":"Liu X, Yao D, Liu C, Cao Y, Yang Q, Sun Z, Liu D. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients. Tumour Biol. 2016;37:8367\u201374. https:\/\/doi.org\/10.1007\/s13277-015-4703-5","journal-title":"Tumour Biol"},{"key":"7537_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.01.007","volume":"90","author":"M Singh","year":"2023","unstructured":"Singh M, Afonso J, Sharma D, Gupta R, Kumar V, Rani R, Baltazar F, Kumar V. Targeting monocarboxylate transporters (MCTs) in cancer: how close are we to the clinics? Semin Cancer Biol. 2023;90:1\u201314. https:\/\/doi.org\/10.1016\/j.semcancer.2023.01.007","journal-title":"Semin Cancer Biol"},{"key":"7537_CR159","doi-asserted-by":"publisher","first-page":"277","DOI":"10.20517\/cdr.2021.134","volume":"5","author":"T Koltai","year":"2022","unstructured":"Koltai T. The complex relationship between multiple drug resistance and the tumor pH gradient: a review. Cancer Drug Resist. 2022;5:277\u2013303. https:\/\/doi.org\/10.20517\/cdr.2021.134","journal-title":"Cancer Drug Resist"},{"key":"7537_CR160","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s00259-010-1504-3","volume":"37","author":"O Thews","year":"2010","unstructured":"Thews O, Dillenburg W, Fellner M, Buchholz HG, Bausbacher N, Schreckenberger M, R\u00f6sch F. Activation of P-glycoprotein (pgp)-mediated drug efflux by extracellular acidosis: in vivo imaging with 68Ga-labelled pet tracer. Eur J Nucl Med Mol Imag. 2010;37:1935\u201342. https:\/\/doi.org\/10.1007\/s00259-010-1504-3","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"7537_CR161","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.biocel.2014.06.016","volume":"54","author":"W Jin","year":"2014","unstructured":"Jin W, Lu Y, Li Q, Wang J, Zhang H, Chang G, Lin Y, Pang T. Down-regulation of the P-glycoprotein relevant for multidrug resistance by intracellular acidification through the crosstalk of MAPK signaling pathways. Int J Biochem Cell Biol. 2014;54:111\u201321. https:\/\/doi.org\/10.1016\/j.biocel.2014.06.016","journal-title":"Int J Biochem Cell Biol"},{"key":"7537_CR162","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/s0006-2952(03)00467-2","volume":"66","author":"BP Mahoney","year":"2003","unstructured":"Mahoney BP, Raghunand N, Baggett B, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol. 2003;66:1207\u201318. https:\/\/doi.org\/10.1016\/s0006-2952(03)00467-2","journal-title":"Biochem Pharmacol"},{"key":"7537_CR163","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1111\/cas.15047","volume":"112","author":"JE Burns","year":"2021","unstructured":"Burns JE, Hurst CD, Knowles MA, Phillips RM, Allison SJ. The warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets. Cancer Sci. 2021;112:3822\u201334. https:\/\/doi.org\/10.1111\/cas.15047","journal-title":"Cancer Sci"},{"key":"7537_CR164","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reyni\u00e8s A, Allory Y, Sj\u00f6dahl G, Robertson AG, Seiler R, Hoadley KA, Groeneveld CS, Al-Ahmadie H, Choi W, Castro MAA, Fontugne J, Eriksson P, Mo Q, Kardos J, Zlotta A, Hartmann A, Dinney CP, Bellmunt J, Powles T, Malats N, Chan KS, Kim WY, McConkey DJ, Black PC, Dyrskj\u00f8t L, H\u00f6glund M, Lerner SP, Real FX, Radvanyi F. A consensus molecular classification of muscle-invasive bladder cancer. Eur Urology. 2020;77:420\u201333. https:\/\/doi.org\/10.1016\/j.eururo.2019.09.006","journal-title":"Eur Urology"},{"key":"7537_CR165","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/path.6060","volume":"259","author":"J Fontugne","year":"2023","unstructured":"Fontugne J, Wong J, Cabel L, Neyret-Kahn H, Karboul N, Maill\u00e9 P, Rapinat A, Gentien D, Nicolas A, Baulande S, Sibony M, Bernard-Pierrot I, Radvanyi F, Allory Y. Progression-associated molecular changes in basal\/squamous and sarcomatoid bladder carcinogenesis. J Pathol. 2023;259:455\u201367. https:\/\/doi.org\/10.1002\/path.6060","journal-title":"J Pathol"},{"key":"7537_CR166","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1038\/s41598-023-33140-z","volume":"13","author":"X Yu","year":"2023","unstructured":"Yu X, Li W, Feng Y, Gao Z, Wu Q, Xia Y. The prognostic value of hedgehog signaling in bladder cancer by integrated bioinformatics. Sci Rep. 2023;13:6241. https:\/\/doi.org\/10.1038\/s41598-023-33140-z","journal-title":"Sci Rep"},{"key":"7537_CR167","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152. https:\/\/doi.org\/10.1186\/1476-4598-12-152","journal-title":"Mol Cancer"},{"key":"7537_CR168","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41419-025-07645-6","volume":"16","author":"Z Lin","year":"2025","unstructured":"Lin Z, Liang F, Hong G, Jiang X, Zhang Q, Wang M. TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-myc. Cell Death Dis. 2025;16:311. https:\/\/doi.org\/10.1038\/s41419-025-07645-6","journal-title":"Cell Death Dis"},{"key":"7537_CR169","doi-asserted-by":"publisher","unstructured":"Fan T, Sun G, Sun X, Zhao L, Zhong R, Peng Y. Tumor energy metabolism and potential of 3-bromopyruvate as an inhibitor of aerobic glycolysis: implications in tumor treatment. Cancers. 2019;11. https:\/\/doi.org\/10.3390\/cancers11030317","DOI":"10.3390\/cancers11030317"},{"key":"7537_CR170","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12943-015-0399-9","volume":"14","author":"EG Konstantakou","year":"2015","unstructured":"Konstantakou EG, Voutsinas GE, Velentzas AD, Basogianni AS, Paronis E, Balafas E, Kostomitsopoulos N, Syrigos KN, Anastasiadou E, Stravopodis DJ. 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants. Mol Cancer. 2015;14:135. https:\/\/doi.org\/10.1186\/s12943-015-0399-9","journal-title":"Mol Cancer"},{"key":"7537_CR171","first-page":"1479","volume":"36","author":"MA Lea","year":"2016","unstructured":"Lea MA, Guzman Y, Desbordes C. Inhibition of growth by combined treatment with inhibitors of lactate dehydrogenase and either phenformin or inhibitors of 6-phosphofructo-2-kinase\/fructose-2, 6-bisphosphatase 3. Anticancer Res. 2016;36:1479\u201388","journal-title":"Anticancer Res"},{"key":"7537_CR172","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7150\/jca.21224","volume":"9","author":"JC Tang","year":"2018","unstructured":"Tang JC, Zhao J, Long F, Chen JY, Mu B, Jiang Z, Ren Y, Yang J. Efficacy of shikonin against esophageal Cancer cells and its possible mechanisms in vitro and in vivo. J Cancer. 2018;9:32\u201340. https:\/\/doi.org\/10.7150\/jca.21224","journal-title":"J Cancer"},{"key":"7537_CR173","first-page":"21","volume":"18","author":"CC Yeh","year":"2004","unstructured":"Yeh CC, Wu LT, Lin SY, Li TM, Chung JG. The inhibition of N-acetyltransferase activity and gene expression in human bladder cancer cells (T24) by shikonin. Vivo. 2004;18:21\u201331","journal-title":"Vivo"},{"key":"7537_CR174","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1200\/jco.2002.08.012","volume":"20","author":"A Berruti","year":"2002","unstructured":"Berruti A, Bitossi R, Gorzegno G, Bottini A, Alquati P, Matteis AD, Nuzzo F, Giardina G, Danese S, Lena MD, Lorusso V, Farris A, Sarobba MG, DeFabiani E, Bonazzi G, Castiglione F, Bumma C, Moro G, Bruzzi P, Dogliotti L. Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase iii study with a factorial design. J Clin Oncol. 2002;20:4150\u201359. https:\/\/doi.org\/10.1200\/jco.2002.08.012","journal-title":"J Clin Oncol"},{"key":"7537_CR175","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/0959-8049(94)00231-s","volume":"30a","author":"A Gadducci","year":"1994","unstructured":"Gadducci A, Brunetti I, Muttini MP, Fanucchi A, Dargenio F, Giannessi PG, Conte PF. Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer. Eur J Cancer. 1994;30a:1432\u201335. https:\/\/doi.org\/10.1016\/0959-8049(94)00231-s","journal-title":"Eur J Cancer"},{"key":"7537_CR176","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1200\/jco.1997.15.10.3208","volume":"15","author":"MD Lena","year":"1997","unstructured":"Lena MD, Lorusso V, Bottalico C, Brandi M, Mitrio AD, Catino A, Guida M, Latorre A, Leone B, Vallejo C, Gargano G. Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum. J Clin Oncol. 1997;15:3208\u201313. https:\/\/doi.org\/10.1200\/jco.1997.15.10.3208","journal-title":"J Clin Oncol"},{"key":"7537_CR177","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/pros.21172","volume":"70","author":"M Stein","year":"2010","unstructured":"Stein M, Lin H, Jeyamohan C, Dvorzhinski D, Gounder M, Bray K, Eddy S, Goodin S, White E, Dipaola RS. Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate. 2010;70:1388\u201394. https:\/\/doi.org\/10.1002\/pros.21172","journal-title":"Prostate"},{"key":"7537_CR178","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1002\/pros.20837","volume":"68","author":"RS DiPaola","year":"2008","unstructured":"DiPaola RS, Dvorzhinski D, Thalasila A, Garikapaty V, Doram D, May M, Bray K, Mathew R, Beaudoin B, Karp C, Stein M, Foran DJ, White E. Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. Prostate. 2008;68:1743\u201352. https:\/\/doi.org\/10.1002\/pros.20837","journal-title":"Prostate"},{"key":"7537_CR179","doi-asserted-by":"publisher","first-page":"e2408599","DOI":"10.1002\/advs.202408599","volume":"12","author":"M Deng","year":"2025","unstructured":"Deng M, Zhou Z, Chen J, Li X, Liu Z, Ye J, Wei W, Wang N, Peng Y, Luo X, Jiang L, Zhou F, Zheng X, Liu Z. Enhanced oxidative phosphorylation driven by TACO1 mitochondrial translocation promotes stemness and cisplatin resistance in bladder cancer. Adv Sci (Weinh). 2025;12:e2408599. https:\/\/doi.org\/10.1002\/advs.202408599","journal-title":"Adv Sci (Weinh)"},{"key":"7537_CR180","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020144","author":"O Renner","year":"2022","unstructured":"Renner O, Mayer M, Leischner C, Burkard M, Berger A, Lauer UM, Venturelli S, Bischoff SC. Systematic review of Gossypol\/AT-101 in cancer clinical trials. Pharmaceuticals (basel). 2022, 15. https:\/\/doi.org\/10.3390\/ph15020144","journal-title":"Pharmaceuticals (basel)"},{"key":"7537_CR181","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12967-021-02825-2","volume":"19","author":"Y Yang","year":"2021","unstructured":"Yang Y, Chong Y, Chen M, Dai W, Zhou X, Ji Y, Qiu G, Du X. Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench. J Transl Med. 2021;19:170. https:\/\/doi.org\/10.1186\/s12967-021-02825-2","journal-title":"J Transl Med"},{"key":"7537_CR182","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1208\/s12248-018-0279-5","volume":"21","author":"X Guan","year":"2019","unstructured":"Guan X, Rodriguez-Cruz V, Morris ME. Cellular uptake of MCT1 inhibitors AR-C155858 and AZD3965 and their effects on MCT-Mediated transport of L-Lactate in murine 4T1 breast tumor cancer cells. Aaps J. 2019;21:13. https:\/\/doi.org\/10.1208\/s12248-018-0279-5","journal-title":"Aaps J"},{"key":"7537_CR183","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41590-023-01738-0","volume":"25","author":"J Ma","year":"2024","unstructured":"Ma J, Tang L, Tan Y, Xiao J, Wei K, Zhang X, Ma Y, Tong S, Chen J, Zhou N, Yang L, Lei Z, Li Y, Lv J, Liu J, Zhang H, Tang K, Zhang Y, Huang B. Lithium carbonate revitalizes tumor-reactive CD8(+) T cells by shunting lactic acid into mitochondria. Nat Immunol. 2024;25:552\u201361. https:\/\/doi.org\/10.1038\/s41590-023-01738-0","journal-title":"Nat Immunol"},{"key":"7537_CR184","doi-asserted-by":"publisher","first-page":"eadd2712","DOI":"10.1126\/scitranslmed.add2712","volume":"15","author":"Z Cao","year":"2023","unstructured":"Cao Z, Xu D, Harding J, Chen W, Liu X, Wang Z, Wang L, Qi T, Chen S, Guo X, Chen ISY, Guo J, Lu Y, Wen J. Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy. Sci Transl Med. 2023;15:eadd2712. https:\/\/doi.org\/10.1126\/scitranslmed.add2712","journal-title":"Sci Transl Med"},{"key":"7537_CR185","doi-asserted-by":"publisher","first-page":"e56437","DOI":"10.15252\/embr.202256437","volume":"24","author":"M Shi","year":"2023","unstructured":"Shi M, Hou J, Liang W, Li Q, Shao S, Ci S, Shu C, Zhao X, Zhao S, Huang M, Wu C, Hu Z, He L, Guo Z, Pan F. GAPDH facilitates homologous recombination repair by stabilizing RAD51 in an HDAC1-dependent manner. EMBO Rep. 2023;24:e56437. https:\/\/doi.org\/10.15252\/embr.202256437","journal-title":"EMBO Rep"},{"key":"7537_CR186","doi-asserted-by":"publisher","first-page":"1630726","DOI":"10.3389\/fonc.2025.1630726","volume":"15","author":"ZQ Liu","year":"2025","unstructured":"Liu ZQ, Yang XY, Chen JH, Ge SC, Dai SX, Zhu SH, Xian ZY. From dysbiosis to precision therapy: decoding the gut-bladder axis in bladder carcinogenesis. Front Oncol. 2025;15:1630726. https:\/\/doi.org\/10.3389\/fonc.2025.1630726","journal-title":"Front Oncol"},{"key":"7537_CR187","doi-asserted-by":"publisher","first-page":"2495183","DOI":"10.1080\/19490976.2025.2495183","volume":"17","author":"Y Xu","year":"2025","unstructured":"Xu Y, Gao Z, Liu J, Yang Q, Xu S. Role of gut microbiome in suppression of cancers. Gut Microbes. 2025;17:2495183. https:\/\/doi.org\/10.1080\/19490976.2025.2495183","journal-title":"Gut Microbes"},{"key":"7537_CR188","doi-asserted-by":"publisher","unstructured":"Ece G, Akta\u015f A, Caner A, Sa\u011fl\u0131k \u0130, Atik TK, Ba\u011fc\u0131 \u00d6U, Bilman FB, Demirbakan H, Havuz SG, Kaya E, \u00d6zyurt \u00d6K, Yetkin G, Zorbozan O. The urogenit system microbiota: is it a new gamechanger in urogenit cancers? Microorganisms. 2025;13. https:\/\/doi.org\/10.3390\/microorganisms13020315","DOI":"10.3390\/microorganisms13020315"},{"key":"7537_CR189","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063462","author":"E Ferreira","year":"2024","unstructured":"Ferreira E, Ferreira D, Relvas-Santos M, Freitas R, Soares J, Azevedo R, Afonso LP, Lima L, Santos B, Gon\u00e7alves M, Silva AMN, Santos LL, Peixoto A, Ferreira JA. Aberrantly glycosylated GLUT1 as a poor prognosis Marker in aggressive bladder cancer. Int J Mol Sci. 2024, 25. https:\/\/doi.org\/10.3390\/ijms25063462","journal-title":"Int J Mol Sci"},{"key":"7537_CR190","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/cac2.12351","volume":"42","author":"J Wang","year":"2022","unstructured":"Wang J, Shao F, Yang Y, Wang W, Yang X, Li R, Cheng H, Sun S, Feng X, Gao Y, He J, Lu Z. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability. Cancer Commun (lond). 2022;42:1008\u201327. https:\/\/doi.org\/10.1002\/cac2.12351","journal-title":"Cancer Commun (lond)"},{"key":"7537_CR191","doi-asserted-by":"publisher","first-page":"e11487","DOI":"10.1016\/j.heliyon.2022.e11487","volume":"8","author":"H Kobayashi","year":"2022","unstructured":"Kobayashi H. Recent advances in understanding the metabolic plasticity of ovarian cancer: a systematic review. Heliyon. 2022;8:e11487. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11487","journal-title":"Heliyon"},{"key":"7537_CR192","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12943-022-01517-9","volume":"21","author":"ZD Shi","year":"2022","unstructured":"Shi ZD, Hao L, Han XX, Wu ZX, Pang K, Dong Y, Qin JX, Wang GY, Zhang XM, Xia T, Liang Q, Zhao Y, Li R, Zhang SQ, Zhang JH, Chen JG, Wang GC, Chen ZS, Han CH. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Mol Cancer. 2022;21:37. https:\/\/doi.org\/10.1186\/s12943-022-01517-9","journal-title":"Mol Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07537-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:36:40Z","timestamp":1768851400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07537-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":192,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7537"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07537-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}